Pfizer, Allergan Near Deal As Tax Inversion Rules Loom

By | November 19, 2015

Scalper1 News

Pfizer (PFE) is near a massive deal to buy Allergan (AGN) and redomicile in Ireland, multiple reports said, even as the Treasury Department plans to impose new restrictions on tax inversions. Pfizer are discussing a deal that would pay $370-$380 a share for Botox maker Allergan, Bloomberg and Reuters reported late Wednesday. Allergan rose 4.5% to 310.83 on Wednesday, but retreated after hours following news of the inversion rules. Allergan traded Scalper1 News

Scalper1 News